NCT00963027 - Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Hypertension, PulmonaryPulmonary Arterial Hypertension

Interventions

DRUG

Treprostinil diethanolamine

Subjects will each receive a single 1 mg sustained release tablet of treprostinil diethanolamine by mouth immediately following breakfast before and after repeated daily dosing with esomeprazole.

DRUG

Esomeprazole

Each subject will receive a single 40 mg capsule of esomeprazole by mouth in the morning for seven days.

Trial Locations (1)

78744

PPD Development, Austin